Author
- 2
Dağlıoğlu, Cenk
- 1
Akdeniz, Esra Şahin
- 1
Avcu, Ferit
- 1
Baran, Y.
- 1
Baran, Yusuf
- 1
Bayram, N.N.
- 1
Demir, Ayşe Banu
- 1
Dinçer, İşoğlu, S.
- 1
Gündüz, Ufuk
- 1
Gür, Bala
- .
next >
Results 1-6 of 6 (Search time: 0.01 seconds).
| Issue Date | Title | Author(s) |
1 | Apr-2019 | Cascade therapy with doxorubicin and survivin-targeted tailored nanoparticles: An effective alternative for sensitization of cancer cells to chemotherapy | Dağlıoğlu, Cenk ; Kacı, Fatma Necmiye |
2 | 2022 | HER2-Targeted, Degradable Core Cross-Linked Micelles for Specific and Dual pH-Sensitive DOX Release | Bayram, N.N.; Ulu, G.T.; Topuzoğulları, M.; Baran, Y. ; Dinçer, İşoğlu, S. |
3 | Dec-2015 | High-copy overexpression screening reveals PDR5 as the main doxorubicin resistance gene in yeast | Demir, Ayşe Banu; Koç, Ahmet |
4 | Mar-2022 | Investigation of interactions of doxorubicin with purine nucleobases by molecular modeling | Akdeniz, Esra Şahin ; Selçuki, Cenk |
5 | 20-Apr-2016 | Synthesis and characterization of AICAR and DOX conjugated multifunctional nanoparticles as a platform for synergistic inhibition of cancer cell growth | Dağlıoğlu, Cenk ; Okutucu, Burcu |
6 | Dec-2007 | Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance | Baran, Yusuf ; Gür, Bala; Kaya, Pelin; Ural, Ali Uğur; Avcu, Ferit; Gündüz, Ufuk |